Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for CAPA (Corrective and Preventive Action) Management – V 2.0

Posted on By

API Manufacturing: SOP for CAPA (Corrective and Preventive Action) Management – V 2.0

Standard Operating Procedure for CAPA (Corrective and Preventive Action) Management in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/163/2025
Supersedes SOP/API/163/2022
Page No. Page 1 of 13
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define a robust and structured system for identifying, documenting, investigating, implementing, and tracking Corrective and Preventive Actions (CAPA) arising from deviations, audits, complaints, change controls, or quality failures in the API manufacturing process.

2. Scope

This SOP applies to all CAPAs initiated within the Quality Assurance (QA), Production, Quality Control (QC), Engineering, and Warehouse

departments of the API manufacturing facility. It covers both product-specific and system-related issues.

3. Responsibilities

  • Initiator: Responsible for raising the CAPA based on identified non-conformance.
  • CAPA Coordinator (QA): Responsible for coordinating investigations, reviews, and closure activities.
  • Department Head: Assists in identifying root cause and implementation of assigned actions.
  • QA Head: Final approver of all CAPAs, ensuring effectiveness and closure.
See also  API Manufacturing: SOP for Monitoring of Solvent Recovery Efficiency - V 2.0

4. Accountability

The Quality Assurance Department is accountable for overall CAPA system implementation, timely execution, and continuous monitoring to prevent recurrence of quality failures.

5. Procedure

5.1 Sources for CAPA Initiation

CAPAs can be initiated from the following sources:

  • Deviations
  • Internal/External Audit Observations
  • Product Complaints
  • Out of Specification (OOS) / Out of Trend (OOT) Results
  • Change Controls
  • Regulatory Inspections

5.2 CAPA Initiation

  1. The concerned department shall raise a CAPA Request using the CAPA Initiation Form (Annexure-1).
  2. The form shall include:
    • Reference source (Deviation No., Audit Observation No., etc.)
    • Brief description of issue
    • Immediate correction (if any)
  3. Submit the form to QA for review and entry into the CAPA Register (Annexure-2).

5.3 Investigation and Root Cause Analysis

  1. The QA representative shall coordinate with relevant department to initiate a detailed investigation.
  2. Investigation techniques may include:
    • 5 Whys Analysis
    • Ishikawa/Fishbone Diagram
    • Brainstorming
  3. Document findings in the CAPA Investigation Report (Annexure-3).

5.4 Corrective and Preventive Action Planning

  1. Based on investigation, define:
    • Corrective Actions: Actions taken to rectify existing non-conformities.
    • Preventive Actions: Actions taken to eliminate potential causes and prevent recurrence.
  2. Assign responsible persons and timelines for each action.
  3. Record actions and due dates in the CAPA Tracker (Annexure-4).
See also  API Manufacturing: SOP for Handling of Exothermic Reactions - V 2.0

5.5 Implementation and Effectiveness Check

  1. All actions must be implemented as per assigned deadlines.
  2. QA shall perform a follow-up to verify the completion and effectiveness of CAPA.
  3. Effectiveness check includes:
    • Audit of revised process or document
    • Training verification
    • Monitoring of post-implementation results

5.6 CAPA Closure

  1. QA shall close the CAPA only after:
    • Completion of all corrective and preventive actions
    • Successful verification of effectiveness
    • Approval by QA Head
  2. Mark the CAPA as ‘Closed’ in the CAPA Register with closure date and remarks.

5.7 Delayed CAPAs

  1. If CAPA is not completed by the due date:
    • Extension may be requested with justification
    • Revised timelines shall be approved by QA Head
  2. Delayed CAPAs shall be highlighted in monthly quality review meetings.

5.8 Trending and Metrics

  1. QA shall analyze CAPA trends monthly for:
    • Frequent issues from the same source
    • Recurrence of similar issues
    • CAPA turnaround time (TAT)
  2. CAPA metrics shall be presented during Management Review Meetings.

6. Abbreviations

  • CAPA: Corrective and Preventive Action
  • QA: Quality Assurance
  • QC: Quality Control
  • OOS: Out of Specification
  • OOT: Out of Trend
See also  API Manufacturing: SOP for Tray Loading for Drying - V 2.0

7. Documents

  1. CAPA Initiation Form (Annexure-1)
  2. CAPA Register (Annexure-2)
  3. CAPA Investigation Report (Annexure-3)
  4. CAPA Tracker (Annexure-4)
  5. Effectiveness Check Template

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211 – Subpart J: Records and Reports
  • WHO TRS No. 981 – Annex 2

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: CAPA Initiation Form

CAPA ID Reference Description Raised By Date
CAPA/2025/014 DEV/2025/032 Repeat deviation during granulation Rajesh Kumar 12/04/2025

Annexure-2: CAPA Register

CAPA ID Date Source Status Closed On
CAPA/2025/014 12/04/2025 Deviation Open —

Annexure-3: CAPA Investigation Report

CAPA ID Root Cause Method Used Investigated By
CAPA/2025/014 Improper setup of granulator 5 Whys Sunita Reddy

Annexure-4: CAPA Tracker

Action Type Responsible Due Date Status
Train operators Preventive QA 20/04/2025 Ongoing

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Version Implementation QA Head
14/04/2025 2.0 Integrated tracker and effectiveness template Improvement QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Biosimilars: SOP for Pressure Vessel Safety Checks in Bioreactor Operations – V 2.0
Next Post: Gel Manufacturing: SOP for Cleaning Storage Tanks for Bulk Gel – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version